FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation (2013)
- Authors:
- Lopes, Matheus Rodrigues - Universidade Estadual de Campinas (UNICAMP)
- Machado Neto, João Agostinho - Universidade Estadual de Campinas (UNICAMP)
- Traina, Fabíola
- Pereira, João Kleber Novais - Universidade Estadual de Campinas (UNICAMP)
- Lorand-Metze, Irene - Universidade Estadual de Campinas (UNICAMP)
- Costa, Fernando Ferreira - Universidade Estadual de Campinas (UNICAMP)
- Saad, Sara Teresinha Ollala - Universidade Estadual de Campinas (UNICAMP)
- Favaro, Patricia - Universidade Federal de São Paulo (UNIFESP)
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- Subjects: DOENÇAS HEMATOLÓGICAS; HEMATOPOESE
- Language: Inglês
- Imprenta:
- Publisher place: New Orleans
- Date published: 2013
- Source:
- Conference titles: Annual Meeting and Exposition of American Society of Hematology (ASH)
-
ABNT
LOPES, Matheus Rodrigues et al. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper60188.html. Acesso em: 25 fev. 2026. -
APA
Lopes, M. R., Machado Neto, J. A., Traina, F., Pereira, J. K. N., Lorand-Metze, I., Costa, F. F., et al. (2013). FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper60188.html -
NLM
Lopes MR, Machado Neto JA, Traina F, Pereira JKN, Lorand-Metze I, Costa FF, Saad STO, Favaro P. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2026 fev. 25 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper60188.html -
Vancouver
Lopes MR, Machado Neto JA, Traina F, Pereira JKN, Lorand-Metze I, Costa FF, Saad STO, Favaro P. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2026 fev. 25 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper60188.html - Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
- FMNL1 promotes proliferation and migration of leukemia cells
- SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype
- IRS1 (insulin receptor substrate 1)
- Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia
- IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients
- Hedgehog pathway is deregulated in myelodysplastic syndrome progenitor bone marrow cells
- Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
